protein
hepat
c
viru
hcv
amino
acid
long
polypeptid
essenti
replic
involv
protein
traffick
proton
transport
therefor
possibl
target
antivir
consensu
model
channel
form
protein
hexamer
heptamer
oligom
ahel
hairpin
monom
two
transmembran
domain
ntermin
would
face
lumen
channel
report
highthroughput
function
assay
search
channel
inhibitor
base
carboxyfluorescein
cf
releas
liposom
addit
howev
rational
dual
abil
serv
ion
proton
channel
infect
cell
permeabil
membran
larg
molecul
like
cf
clear
recreat
activ
vitro
examin
conform
present
assay
use
infrar
spectroscopi
result
indic
ahel
form
transport
proton
abl
elicit
cf
releas
contrast
membran
permeabil
cf
observ
contain
high
percentag
bstructur
use
ctermin
fragment
encompass
propos
report
inhibitori
effect
small
compound
eg
rimantadin
cf
releas
proton
transport
explain
via
bind
membraneinsert
ctermin
half
increas
rigid
similar
way
influenza
interact
hepat
c
viru
hcv
chronic
infect
million
peopl
worldwid
prophylact
therapeut
vaccin
avail
protein
encod
hcv
small
transmembran
tm
protein
residu
long
found
mainli
endoplasm
reticulum
er
membran
although
necessari
rna
replic
essenti
infect
assembl
releas
infecti
virion
oligom
form
show
cationselect
channel
activ
block
case
amantadin
rimantadin
hexamethylen
amilorid
hma
longalkylchain
imino
sugar
deriv
recent
membran
permeabil
proton
found
crucial
product
infecti
virus
observ
intracellular
vesicl
harbor
addit
involv
capsid
assembl
envelop
local
sever
viral
protein
possibl
via
channelindepend
mechan
protein
predict
two
ahel
tm
domain
detail
three
dimension
structur
limit
solut
nmr
data
obtain
synthet
mutant
tfe
helix
induc
recombin
mutant
dhpc
micel
paper
report
similar
percentag
ahelix
predict
ahel
hairpin
two
ahel
tm
kink
middl
ntermin
tm
helix
would
face
lumen
channel
form
either
six
seven
monom
recent
model
form
mostli
ahel
domain
report
dpc
micel
electron
microscopi
altern
topolog
conform
report
literatur
exampl
use
ectodomain
myc
epitop
tag
nand
ctermini
expos
extracellularli
consist
ahel
hairpin
form
two
tm
domain
howev
nontag
show
cytoplasm
orient
cterminu
compat
form
one
tm
domain
recent
two
differ
cd
spectra
srcd
one
consist
ahel
form
anoth
assign
particular
structur
show
channel
activ
obtain
protein
reconstitut
membran
vari
pc
pe
ratio
overal
data
indic
topolog
conform
may
uniqu
addit
ion
proton
channel
activ
also
shown
previous
permeabil
liposom
induc
releas
carboxyfluorescein
cf
ad
cfload
liposom
claim
sensit
procedur
inhibitor
rimantadin
also
propos
author
inhibit
ion
channel
activ
result
method
propos
function
assay
test
mutant
discov
channel
activ
inhibitor
howev
presum
dual
abil
oligom
form
ahel
hairpin
serv
channel
small
ion
proton
facilit
larg
molecul
like
cf
puzzl
thu
hypothes
conform
two
case
yet
activ
inhibit
similar
small
molecul
indic
bind
mode
drug
two
instanc
must
similar
inhibit
two
activ
must
base
similar
mechan
thu
establish
correl
conform
divers
activ
studi
effect
solvent
type
reconstitut
structur
featur
protein
use
attenu
total
reflect
fourier
transform
infrar
atrftir
spectroscopi
techniqu
especi
suitabl
studi
lipid
bilay
use
three
method
reconstitut
lipid
membran
first
two
method
coreconstitut
protein
dri
solvent
lipid
either
aid
deterg
dialysi
method
without
deterg
direct
method
two
procedur
may
follow
freezethaw
extrus
protocol
third
method
addit
method
ad
directli
solvent
preform
liposom
cfreleas
assay
method
use
previous
literatur
abil
elicit
cf
releas
proton
transport
test
control
condit
conform
known
allow
infer
ahel
hairpin
form
respons
proton
transport
cf
releas
nucleotid
sequenc
correspond
hcv
subtyp
strain
obtain
ncbi
access
number
ncbi
id
gene
synthes
puriti
determin
agaros
gel
electrophoresi
gene
clone
ptbmale
vector
mbp
fusion
partner
carri
histag
nterminu
form
construct
experi
addit
flag
tag
ad
ntermin
insert
mutagenesi
use
appropri
set
primer
form
construct
dna
plasmid
contain
gene
transform
e
coli
compet
cell
strain
codonplusril
stratagen
protein
overexpress
cell
singl
coloni
pick
inocul
ml
lb
media
mgml
ampicillin
mgml
chloramphenicol
grown
overnight
shake
volum
ml
overnight
cultur
transfer
ml
terrif
broth
tb
media
dilut
grown
shake
od
cell
induc
mm
isopropylbthiogalactosid
iptg
grown
overnight
shake
nlabel
sampl
cell
harvest
od
reach
wash
minim
media
cell
transfer
minim
media
contain
n
ammonium
chlorid
high
cell
densiti
strategi
employ
concentr
cultur
media
enhanc
express
level
minim
media
induct
cell
harvest
resuspend
ni
nta
bind
buffer
contain
mm
trishcl
mm
nacl
mm
imidazol
ph
kept
frozen
overnight
thaw
cell
incub
mgml
lysozym
mgml
benzonas
min
ad
sampl
final
concentr
cell
lyse
microfluid
kpsi
pressur
supernat
collect
centrifug
g
min
load
econo
column
biorad
pack
ni
nta
agaros
resin
qiagen
preequilibr
bind
buffer
fusion
protein
allow
bind
resin
gentl
shake
overnight
nickel
resin
bound
fusion
protein
wash
column
volum
buffer
contain
mm
trishcl
mm
nacl
mm
imidazol
ph
remov
unbound
protein
bound
protein
elut
elut
buffer
contain
mm
trishcl
mm
nacl
mm
imidazol
ph
mm
fraction
collect
store
fraction
contain
fusion
protein
check
sdspage
express
purif
tev
proteas
done
similar
way
protein
except
deterg
ad
sampl
solubl
protein
tev
store
buffer
contain
glycerol
mm
trishcl
mm
nacl
mm
imidazol
mm
edta
mm
dtt
ph
purif
use
ni
nta
resin
construct
subject
tev
enzymat
cleavag
order
remov
mbp
tev
proteas
ad
fusion
protein
mass
ratio
tev
fusion
protein
digest
perform
room
temperatur
gentl
shake
progress
reaction
monitor
sdspage
digest
stop
addit
trichloroacet
acid
tca
final
concentr
volum
precipit
collect
centrifug
g
min
pellet
wash
water
twice
follow
lyophil
extract
methanol
ml
methanol
per
cultur
mix
gentli
hour
room
temperatur
remov
insolubl
fraction
centrifug
g
min
supernat
contain
mostli
protein
protein
purifi
inject
supernat
onto
zorbax
column
connect
hplc
system
protein
elut
linear
gradient
solvent
watertfa
vv
solvent
b
isopropanol
acetonitriletfa
vvv
pool
fraction
lyophil
puriti
assess
mass
spectrometri
tev
cleavag
result
addit
ntermin
sna
residu
describ
ntermin
methionin
also
includ
altern
cleavag
point
cnbr
case
enzymat
cleavag
success
channel
activ
protein
test
black
lipid
membran
fig
file
synthet
peptid
obtain
solidphas
synthesi
use
fmoc
chemistri
synthet
purifi
rphplc
describ
recombin
protein
hepat
c
viru
hcv
use
amino
acid
fragment
synthes
manual
mbha
resin
use
standard
tertbutoxycarbonyl
boc
chemistri
thioester
group
incorpor
resin
chain
elong
deprotect
done
trifluoroacet
acid
tfa
monitor
coupl
deprotect
step
use
ninhydrin
test
final
peptid
cleavag
resin
achiev
hydrogen
fluorid
hf
fragment
synthes
microwav
assist
solid
phase
fluorenylmethyloxycarbonyl
fmoc
chemistri
use
odyssey
microwav
peptid
synthes
cem
corpor
fragment
purifi
rphplc
column
linear
acetonitril
gradient
puriti
check
sd
electrophoresi
fig
file
maldi
fig
file
two
peptid
ligat
urea
mm
dpc
mm
tcep
mm
mesna
catalyz
mm
phosphat
buffer
ph
h
hplc
chromatogram
show
fragment
consum
reaction
sd
electrophoresi
show
band
correspond
full
length
h
reaction
fig
file
maldi
mass
spectrum
reaction
mixtur
fig
file
show
presenc
ligat
polypeptid
standard
sdspage
perform
dtt
trisglycin
gel
tg
run
buffer
nupag
nonreduc
condit
bistri
gel
messd
run
buffer
accord
manufactur
protocol
invitrogen
sampl
mg
final
concentr
mgml
mix
sampl
buffer
min
follow
heat
min
load
gel
gel
run
constant
voltag
v
min
room
temperatur
standard
sdspage
gel
stain
coomassi
blue
nupag
gel
stain
simplyblu
safestain
invitrogen
silver
stain
biorad
atrftir
spectra
record
describ
previous
approxim
ml
sampl
water
lipidprotein
molar
ratio
appli
onto
trapezoid
mm
ge
intern
reflect
element
ire
area
amid
c
stretch
obtain
peak
integr
cm
area
amid
ii
nh
bend
center
cm
obtain
peak
integr
cm
cm
differ
band
area
observ
employ
mean
peak
size
estim
peak
fit
fourier
selfdeconvolut
hydrogendeuterium
exchang
experi
exchang
calcul
measur
rel
area
amid
ii
rel
amid
band
addit
formula
calcul
percentag
nonexchang
amino
acid
describ
previous
use
three
method
reconstitut
start
recombin
synthet
sampl
solubil
suitabl
solvent
eg
methanol
hfip
first
dialysi
method
solubil
organ
solvent
first
dri
n
ga
follow
overnight
lyophil
reconstitut
dmpc
lipid
bilay
perform
solubil
protein
mm
dhpc
follow
mix
dmpc
lipid
mixtur
left
room
temperatur
h
follow
deterg
remov
biobead
biorad
last
step
repeat
three
time
order
complet
remov
deterg
indic
mixtur
extrud
nm
pore
size
membran
second
direct
method
solut
mix
chloroform
solut
contain
dmpc
avanti
polar
lipid
mixtur
dri
remov
solvent
dri
residu
hydrat
mm
phosphat
buffer
ph
form
liposom
indic
suspens
subsequ
vortex
freezethaw
time
extrud
nm
pore
size
membran
dmpc
dopc
pope
lipid
mixtur
ww
ratio
also
use
third
addit
method
liposom
extrud
first
nm
pore
size
membran
get
small
unilamellar
liposom
protein
stock
organ
solvent
mgml
solut
ad
liposom
solut
protein
lipid
molar
ratio
two
variant
liposom
cf
releas
assay
perform
first
case
ad
preform
cfload
liposom
appropri
volum
ml
buffer
mm
kh
po
mm
k
hpo
mm
nacl
mm
kcl
ph
contain
carboxyfluorescein
cf
selfquench
concentr
mm
use
rehydr
dri
lipid
mgml
follow
three
freezethaw
cycl
extrus
mm
membran
filter
produc
unilamellar
liposom
nonincorpor
cf
dye
remov
use
econopach
dg
column
biorad
initi
liposom
cf
releas
assay
liposom
solut
dilut
buffer
aliquot
microtit
plate
ml
well
typic
mg
protein
dissolv
either
ml
hfip
final
volum
ml
methanol
final
volum
ad
liposom
solut
fluoresc
valu
read
everi
minut
min
rimantadin
prepar
ethanol
vv
ad
liposom
solut
final
concentr
mm
second
case
b
ad
dri
lipid
prior
hydrat
proteinlipid
suspens
subsequ
freezethaw
extrud
separ
nonincorpor
cf
manner
describ
fluoresc
valu
read
immedi
one
hour
fluoresc
measur
perform
tecan
micropl
reader
model
infinit
pro
excit
emiss
nm
nm
respect
baselin
fluoresc
determin
sampl
ident
describ
except
protein
ad
addit
triton
final
concentr
vv
use
posit
control
cf
releas
melittin
honey
bee
venom
also
use
control
purchas
sigmaaldrich
use
without
treatment
polypeptid
solubil
either
hfip
methanol
prior
mix
e
coli
lipid
avanti
polar
lipid
lipid
mixtur
paesc
ie
papepspc
ww
chloroform
protein
lipid
molar
ratio
mixtur
dri
nitrogen
ga
liposom
form
strong
buffer
mm
kh
po
mm
k
hpo
mm
nacl
mm
kcl
ph
lipid
concentr
mgml
extrud
time
mm
polycarbon
membran
extern
solut
exchang
weaker
buffer
mm
na
mm
kh
po
mm
k
hpo
ph
econopach
dg
column
biorad
column
preequilibr
weakli
buffer
extern
buffer
ml
buffer
use
elut
liposom
fraction
column
liposom
fraction
dilut
weak
extern
buffer
approxim
mgml
prior
assay
highli
sensit
ph
probe
mettler
toledo
inlabhmicro
place
experiment
cuvett
contain
ml
liposom
proton
transport
dye
releas
activ
solut
weak
buffer
experi
initi
lower
extern
buffer
ph
addit
hcl
ph
baselin
stabl
min
potassium
ionophor
valinomycin
final
concentr
nm
ad
solut
min
proton
ionophor
carbonyl
cyanid
mchlorophenylhydrazon
cccp
final
concentr
mm
ad
termin
assay
allow
influx
proton
reach
equilibrium
final
solut
backtitr
minut
hcl
inhibit
proton
transport
monitor
addit
mm
rimantadin
inhibitor
ad
concentr
stock
solut
ethanol
minut
initi
proton
transport
assay
hcl
comparison
similar
assay
influenza
protein
proteintolipid
molar
ratio
also
perform
fragment
presolubil
either
methanol
hfip
result
chang
shown
durat
experi
solut
constantli
stir
flotat
assay
proteoliposom
prepar
either
dyalisi
method
extrus
addit
method
briefli
appropri
volum
liposom
sampl
contain
mg
peptid
obtain
either
method
incorpor
modifi
assay
buffer
mm
nah
po
mm
na
hpo
mm
nacl
ph
mix
sucros
wv
na
co
sampl
layer
bottom
centrifug
tube
success
ml
wv
sucros
solut
assay
buffer
ml
assay
buffer
layer
top
sampl
liposomecontain
fraction
dilut
centrifug
g
h
resuspend
water
desalt
pass
econopach
dg
column
biorad
remov
salt
sucros
subsequ
sampl
deposit
onto
germanium
trapezoid
plate
detect
secondari
structur
determin
estim
quantiti
protein
liposom
fraction
calibr
plot
obtain
use
increas
amount
dissolv
hfip
dri
onto
ge
plate
amount
correl
amid
peak
area
cm
use
construct
calibr
line
gelbas
quantif
purpos
dialyz
sampl
tca
precipit
dissolv
nupag
sampl
buffer
electrophores
describ
previou
section
paesc
compon
densiti
molecular
weight
calcul
egg
pabrain
pebrain
psegg
pc
valu
obtain
avanti
websit
wwwavantilipid
com
sucros
buffer
densiti
calcul
use
sednterp
calcul
paesc
lipid
area
egg
yolk
pc
area
use
refer
puriti
synthet
recombin
protein
dye
releas
assay
previous
perform
tag
protein
either
flag
fluantigen
experi
use
essenti
tagfre
either
synthet
recombin
sequenc
recombin
protein
use
present
work
shown
fig
includ
extra
ntermin
residu
snam
wherea
sequenc
synthet
peptid
start
met
residu
fig
fusion
protein
express
moder
level
iptg
induct
fig
purif
use
ni
nta
resin
fig
fusion
protein
subject
tobaccoetch
viru
tev
proteas
cleavag
remov
approxim
cleavag
achiev
h
fig
chang
observ
overnight
reaction
protein
success
purifi
rphplc
use
isopropanol
gradient
fig
pool
fraction
lyophil
puriti
assess
malditof
ms
fig
synthet
also
purifi
rphplc
shown
mass
spectrum
relev
fraction
also
show
one
peak
expect
mass
fig
synthet
recombin
subsequ
lyophil
resolubil
methanol
hfip
solvent
indic
prior
reconstitut
lipid
bilay
effect
reconstitut
protocol
secondari
structur
secondari
structur
studi
use
atrftir
spectroscopi
compar
three
method
reconstitut
dialysi
direct
addit
see
materi
method
experi
freezedri
first
solubil
either
methanol
hfip
h
test
effect
solvent
conform
dialysi
method
recombin
first
dri
hfip
solubil
deterg
reconstitut
dmpc
lipid
bilay
amid
spectrum
show
protein
ahel
trace
h
fig
henceforth
refer
form
peak
center
cm
contrast
recombin
solubil
first
methanol
band
center
cm
appear
promin
indic
approxim
mixtur
ahelix
bstrand
respect
trace
fig
henceforth
refer
form
b
similar
differ
observ
use
synthet
form
shown
thu
regardless
sampl
origin
dramat
increas
bstructur
observ
protein
presolubil
dri
methanol
solut
ahel
form
analysi
amid
region
show
bstructur
constitut
approxim
total
wherea
ahelix
content
ie
amino
acid
ahel
content
consist
report
obtain
recombin
dhpc
micel
obtain
synthet
dissolv
tfe
recent
nmr
structur
variant
dpc
micel
also
mostli
ahel
roughli
consist
ahel
hairpin
model
two
ahel
tm
domain
contrast
form
b
obtain
methanol
solubil
show
bstructur
ahel
content
respect
correspond
residu
form
ahelic
short
account
two
predict
ahel
tm
domain
long
singl
tm
domain
therefor
sampl
like
contain
incomplet
incorrectli
reconstitut
protein
direct
method
use
direct
method
reconstitut
ie
without
deterg
solubil
step
result
ident
dialysi
method
specif
sampl
dri
methanol
form
bstructur
fig
curv
wherea
expos
hfip
h
mostli
ahel
data
shown
howev
sampl
subsequ
vortex
freezethaw
sonic
repeatedli
extrud
bstructur
content
reduc
sampl
becam
mostli
ahel
ie
form
spectra
fig
phenomenon
also
observ
sampl
show
initi
high
content
b
structur
obtain
dyalisi
method
fig
see
addit
see
addit
method
addit
method
use
dye
cf
releas
assay
small
volum
solventsolubil
ad
preform
liposom
aqueou
buffer
case
form
signific
proport
bstructur
fig
see
band
cm
regardless
solvent
use
solubil
prior
addit
liposom
methanol
hfip
tfe
presenc
b
structur
dyalisi
addit
sampl
methanol
use
fig
may
explain
comparison
spectra
dri
hfip
methanol
solut
fig
first
case
almost
complet
ahel
wherea
second
case
contain
bstructur
howev
cd
spectra
hfip
methanol
solut
show
differ
high
percentag
helic
structur
data
shown
therefor
conclud
dri
procedur
induc
bstructur
format
solvent
per
se
bstructur
retain
even
reconstitut
lipid
unless
sampl
extrud
repeatedli
afterward
also
explain
ad
preform
liposom
adopt
bstructur
regardless
solvent
use
fig
predominantli
ahel
solvent
poor
incorpor
bilay
briefli
expos
aqueou
environ
result
bstructur
format
although
sampl
shown
fig
show
high
percentag
bstructur
possibl
heterogen
fraction
popul
insert
membran
well
fold
ahel
inde
percentag
insert
protein
use
addit
method
previous
report
rang
proton
transport
dye
releas
activ
plo
one
wwwplosoneorg
use
western
blot
thu
compar
conform
fraction
incorpor
liposom
membran
use
dyalisi
method
extrus
use
addit
method
initi
attempt
use
detect
westernblot
howev
flag
construct
elicit
cf
releas
use
addit
method
even
though
purifi
way
nontag
pure
shown
therefor
work
test
presenc
liposom
perform
nontag
protein
presenc
directli
monitor
use
sdspage
pure
protein
thu
two
method
dialysi
extrud
ii
addit
use
flotat
experi
separ
membraneincorpor
nonincorpor
protein
fig
assess
secondari
structur
sampl
found
fraction
lip
pel
similar
proport
fig
ie
inde
incorpor
liposom
membran
sampl
substanti
part
protein
appear
aggreg
accumul
top
gel
white
arrow
clearli
defin
oligom
black
dot
arrow
presenc
high
oligomer
form
may
due
tca
precipit
prior
sd
solubil
noteworthi
consider
fraction
also
found
pel
fraction
fig
lane
pel
despit
fact
bulk
extrud
sampl
ahel
fig
suggest
pel
fraction
mere
protein
precipit
must
also
contain
lipid
test
analyz
dynam
light
scatter
dl
content
flotat
tube
top
bottom
ml
fraction
result
show
liposom
also
present
bottom
tube
sampl
fig
file
latter
suggest
fraction
liposom
contain
excess
proport
protein
incorpor
sink
bottom
tube
estim
densiti
lipid
fraction
paesc
liposom
gml
wherea
proton
transport
dye
releas
activ
plo
one
wwwplosoneorg
densiti
three
phase
use
sucros
gradient
gml
respect
therefor
pure
liposom
accumul
interfac
sucros
lipidtoprotein
ratio
molar
use
experi
assum
uniform
incorpor
densiti
liposom
gml
therefor
liposom
still
accumul
interfac
howev
incorpor
homogen
eg
lipid
protein
ratio
liposom
would
found
section
result
observ
fig
file
indic
liposom
contain
correspond
ratio
found
bottom
sucros
section
test
ahel
incorpor
membran
protein
isol
two
condit
lip
pel
fraction
measur
atrftir
experi
consist
result
shown
fig
wherea
extrus
sampl
lip
fraction
adopt
clearli
ahel
conform
lip
fraction
recov
addit
contain
bstructur
fig
de
similar
result
obtain
pel
fraction
condit
shown
thu
although
discard
possibl
addit
fraction
popul
insert
liposom
membran
form
clear
dyalisisextrud
sampl
predominantli
ahel
form
respons
cf
releas
shown
previous
permeabil
liposom
induc
releas
larg
dye
carboxyfluorescein
cf
observ
signific
differ
magnitud
kinet
cf
releas
solubil
tfe
hfip
methanol
ad
paesc
liposom
fig
consist
similar
bstructur
content
prepar
fig
test
incorrectli
incorpor
form
respons
cf
releas
compar
cfreleas
result
addit
experi
use
fragment
form
ahel
hairpin
nativ
structur
correspond
hydrophob
extramembran
loop
wherea
correspond
hydrophyl
hydrophob
fragment
effici
full
length
releas
cf
although
less
melittin
fig
wherea
elicit
cf
releas
comparison
use
similar
hydrophob
protein
singl
transmembran
tm
domain
peptid
influenza
caus
minor
cf
releas
fig
file
suggest
cf
releas
may
specif
ctermin
region
summari
result
show
correct
incorpor
nativ
conform
full
length
necessari
elicit
cf
releas
insert
fraction
lipid
bilay
may
suffici
base
hydrophob
natur
note
recent
publish
structur
model
would
correspond
three
helic
segment
ie
test
form
respons
cf
releas
incorpor
cfcontain
paesc
liposom
dyalisi
method
freezethaw
extrus
result
incorpor
membran
ahel
form
see
fig
fig
howev
remov
non
incorpor
cf
signific
differ
fluoresc
observ
cfload
control
without
sampl
liposom
fig
white
bar
differ
observ
even
h
remov
nonincorpor
cf
cf
still
encapsul
shown
larg
increas
fluoresc
triton
addit
prepar
fig
grey
bar
kinet
cf
releas
also
similar
addit
methanol
liposom
fig
thu
result
experi
incompat
form
respons
cf
releas
local
permeabil
domain
cf
releas
affect
mutat
chang
conform
liposom
insert
eg
ala
mutant
genotyp
context
author
show
mutant
could
form
oligom
deterg
could
insert
membran
howev
least
abl
produc
cf
releas
also
least
abl
insert
liposom
ficol
gradient
experi
basic
residu
locat
loop
region
separ
previou
report
residu
also
appear
two
helic
segment
recent
structur
dpc
micel
propos
line
lumen
channel
region
encompass
residu
interhel
loop
region
predict
ahel
tfe
ahel
dhpc
micel
fig
file
anoth
studi
synthet
peptid
correspond
loop
produc
bstructur
presenc
lipid
bilay
stretch
amino
acid
found
effici
disrupt
liposom
integr
region
around
loop
contain
abund
bbranch
side
chain
v
bulki
residu
f
w
disfavor
ahel
conform
thu
small
loop
region
candid
elicit
cf
releas
although
alon
account
extent
bstructur
found
form
b
fig
may
like
contribut
either
identifi
region
form
bstructur
form
b
attempt
perform
nativ
chemic
ligat
ctermin
thioester
encompass
encompass
ntermin
cystein
fig
file
success
ligat
differenti
c
label
fragment
roughli
correspond
would
produc
hybrid
sampl
result
could
easili
interpret
ir
ligat
success
produc
suffici
yield
fig
file
nevertheless
two
peptid
analyz
independ
atrftir
synthet
ntermin
peptid
total
insolubl
tfe
deterg
difficulti
handl
purif
ntermin
fragment
report
previous
proton
transport
dye
releas
activ
plo
one
wwwplosoneorg
solubil
methanol
direct
reconstitut
dmpc
liposom
produc
spectrum
amid
consist
bstructur
fig
ab
dot
line
high
content
bstructur
also
observ
peptid
previous
solubil
hfip
fig
ab
solid
line
ctermin
peptid
contrast
ahel
condit
test
fig
cd
although
bstructur
methanol
condit
nevertheless
remark
neither
tm
domain
especi
behav
like
typic
ahel
tm
domain
similar
membran
protein
exampl
ahel
tm
domain
integrin
phospholamban
influenza
sarscov
e
rsv
sh
produc
sharp
amid
band
infrar
spectrum
consist
ahelix
agreement
note
ntermin
half
hydrophil
predict
hydrophob
segment
start
residu
short
form
tm
ahelix
contrast
appropri
length
hydrophob
constitut
real
ahel
tm
base
consider
may
difficult
incorpor
lipid
bilay
like
fold
form
bstructur
present
total
partial
expos
peptid
aqueou
solut
certain
reconstitut
condit
examin
condit
obtain
form
consist
ahel
hairpin
mostli
helic
structur
test
abil
form
transport
proton
proton
channel
activ
observ
infect
mammalian
cell
act
prevent
acidif
intracellular
vesicl
found
essenti
product
hcv
infect
howev
result
vitro
assay
use
purifi
protein
report
knowledg
perform
proton
transport
assay
alkalin
extern
solut
measur
gener
ph
gradient
addit
valinomycin
see
materi
method
first
test
dri
hfip
h
methanol
reconstitut
direct
method
sever
extrus
cycleswher
form
obtain
fig
curv
would
equal
abl
transport
proton
tri
sever
lipid
composit
experiment
condit
except
peptid
ad
methanol
peptid
lipid
molar
ratio
error
bar
sd
result
independ
measur
c
experi
incorpor
liposom
dyalisi
method
freezethaw
extrus
fluoresc
valu
measur
immedi
h
remov
excess
cf
one
hour
h
liposom
without
use
control
ad
measur
total
amount
cf
incorpor
error
bar
sd
shown
one
trace
clariti
result
independ
measur
b
effect
observ
liposom
preincub
mm
rimantadin
kinet
cf
releas
liposom
extrud
repres
sampl
contain
reconstitut
without
deterg
solubil
step
respect
proton
transport
dye
releas
activ
plo
one
wwwplosoneorg
h
fig
found
activ
mixtur
paesc
papepspc
ww
similar
result
obtain
proton
channel
activ
less
effici
e
coli
lipid
complet
inact
mixtur
pacc
papepc
chol
ww
lipid
composit
test
shown
paesc
composit
also
previous
found
suitabl
storag
stabil
liposom
cf
releas
highthroughput
assay
ph
chang
observ
significantli
larger
measur
control
liposom
trace
paesc
fig
dph
min
total
ph
chang
min
valinomycin
addit
fig
significantli
larger
oneway
anova
h
dph
min
dph
min
probabl
due
incomplet
convers
form
extrus
nevertheless
prepar
abl
transport
proton
concentr
depend
fashion
comparison
use
influenza
fragment
classic
proton
channel
effici
dph
min
even
protein
lipid
ratio
time
lower
see
materi
method
rimantadin
mm
partial
inhibit
proton
channel
activ
fig
consist
previou
observ
overal
result
show
form
consist
ahel
hairpin
respons
proton
transport
could
test
form
b
also
transport
proton
proton
transport
assay
requir
extrus
produc
unilamellar
liposom
inevit
convert
form
b
fig
test
fragment
encompass
transport
proton
fig
fragment
abl
transport
proton
extent
although
linear
plot
suggest
permeabl
may
specif
total
ph
chang
min
valinomycin
addit
still
significantli
larger
oneway
anova
dph
min
dph
min
howev
may
simpli
reflect
difficult
incorpor
lipid
bilay
conclus
experi
summar
cartoon
represent
fig
form
b
one
tm
insert
lipid
bilay
wherea
interhel
loop
form
predominantli
bstructur
may
partial
insert
membran
propos
form
respons
cf
releas
see
black
arrow
form
contrast
abl
allow
cf
releas
although
abl
transport
proton
grey
arrow
model
assum
site
inhibit
support
observ
direct
interact
inhibitor
amantadin
leucin
shown
unequivoc
part
membran
insert
ahelix
leu
ala
mutat
region
produc
amantadin
resist
mutant
howev
amantadin
rimantadin
also
report
interact
residu
form
ahel
hairpin
thu
propos
drug
interact
membraneinsert
possibl
increas
rigid
prevent
cf
releas
form
b
present
interact
inhibit
proton
channel
activ
form
present
inde
amantadin
abl
interact
recent
confirm
experiment
use
dpc
micel
although
strain
use
quit
differ
sequenc
subtyp
strain
report
less
ident
sequenc
use
overal
result
suggest
although
cf
releas
assay
may
abl
detect
channel
inhibitor
propos
depend
cf
releas
membraneinsert
proton
ion
transport
assay
relev
discov
channel
blocker
model
shown
fig
could
argu
form
b
transport
proton
ion
line
chanel
howev
although
recent
nmr
base
model
place
line
lumen
still
controversi
point
support
arrang
found
physicochem
properti
molecular
dynam
simul
observ
partial
inhibit
channel
activ
cu
mg
peptid
correspond
eg
easili
aggreg
individu
channel
activ
properli
measur
latter
paper
peptid
show
channel
activ
probabl
nonspecif
inhibit
data
report
peptid
purifi
report
unabl
measur
channel
activ
peptid
show
purifi
peptid
even
ahel
presenc
lipid
bilay
methanol
exposur
partial
helic
hfip
exposur
although
propos
form
b
simpli
artifact
possibl
polypeptid
cleav
process
equilibrium
establish
form
b
total
partial
expos
aqueou
domain
lead
coexist
two
conform
may
explain
differ
topolog
report
literatur
rare
viral
protein
n
terminu
hcv
report
assum
dual
tm
topolog
possibl
distinct
function
side
er
membran
addit
hepat
b
viru
surfac
lglycoprotein
also
adopt
differ
tm
topolog
act
viru
assembl
matrixlik
protein
viru
entri
receptorbind
protein
lastli
newcastl
diseas
viru
fusion
protein
exist
two
topolog
form
respect
membran
one
propos
involv
fusion
inde
function
independ
ion
proton
channel
activ
affect
either
channel
inactiv
mutat
treatment
rimantadin
exampl
local
protein
site
viral
replic
lipid
raft
region
transfer
hcv
core
protein
lipid
droplet
er
depend
interact
incident
role
interact
propos
special
import
also
interact
viral
structur
nonstructur
protein
import
promot
viru
assembl
releas
lastli
although
present
result
obtain
subtyp
like
result
extrapol
studi
use
differ
subtyp
hcv
ident
sequenc
subtyp
virus
econom
use
resourc
often
encount
singl
protein
perform
varieti
task
involv
invas
host
cell
evas
host
defens
system
conform
flexibl
recogn
one
featur
necessari
provid
function
file
file
contain
figur
singl
channel
record
synthet
ion
channel
dphpc
lipid
membran
incorpor
ad
mm
methanol
solut
protein
onto
previous
form
lipid
membran
seal
b
ion
channel
activ
block
hma
full
trace
differ
voltag
five
minut
similar
result
obtain
recombin
shown
figur
gel
electrophoresi
recombin
synthet
synthet
fragment
left
trisglycin
gel
reduc
condit
right
nupag
gel
nonreduc
condit
see
materi
method
detail
figur
mass
spectrometri
synthet
fragment
thioester
expect
mass
da
expect
mass
da
b
figur
sequenc
hcv
protein
top
ligat
point
cy
downward
arrow
b
hplc
elut
profil
hcv
protein
ligat
mixtur
h
elut
fragment
b
h
fragment
consum
c
sd
page
ligat
product
h
reaction
arrow
peptid
b
star
product
remain
insid
column
elut
isopropanol
see
fig
file
figur
maldi
mass
spectra
hcv
protein
ligat
mixtur
h
b
ligat
product
purifi
hplc
form
b
embed
lipid
bilay
extra
bstructur
contribut
exposur
aqueou
environ
form
abl
releas
cf
black
arrow
proton
grey
arrow
part
b
form
extend
extramembran
domain
like
particip
fusion
event
membran
destabil
form
two
tm
domain
separ
loop
line
lumen
channel
form
unabl
releas
cf
abl
transport
proton
figur
averag
count
rate
versu
sampl
fraction
flotat
experi
extrud
sampl
deterg
remov
extrus
b
sampl
addit
c
autocorrel
function
acf
sampl
b
fraction
indic
left
sucros
concentr
shown
right
calcul
size
last
fraction
sampl
extrud
addit
nm
respect
sampl
sucros
fraction
averag
size
smaller
nm
sampl
shown
figur
cf
releas
kinet
follow
addit
extrus
comparison
cf
releas
addit
method
use
melittin
methanol
detail
indic
materi
method
section
manuscript
figur
region
adopt
ahel
conform
accord
previou
report
stretch
correspond
ahel
region
underlin
report
tfe
dhpc
micel
b
accord
nmr
experi
sequenc
correspond
genotyp
differ
strain
hcvj
b
approxim
region
span
loop
region
produc
maxim
membran
perturb
grey
bar
indic
differ
sequenc
indic
bold
letter
docx
conceiv
design
experi
swg
jt
ws
perform
experi
swg
ws
av
analyz
data
swg
ws
jt
av
contribut
reagentsmaterialsanalysi
tool
jt
wrote
paper
jt
ws
